124 related articles for article (PubMed ID: 4043177)
1. Relation between enzymatic activities and the degree of malignancy of human lymphomas.
Vezzoni P; Giardini R; Raineri M; Pozzi MR; Lucchini R; Vezzoni MA; Clerici L; Besana C; Rugarli C; Rilke F
Eur J Cancer Clin Oncol; 1985 Aug; 21(8):945-50. PubMed ID: 4043177
[TBL] [Abstract][Full Text] [Related]
2. Multienzymatic analyses of human malignant lymphomas. Correlation of enzymatic data with pathologic and ultrastructural findings in Burkitt's and lymphoblastic lymphomas.
Vezzoni P; Giardini R; Lombardi L; Rilke F; Lucchini R; Vezzoni MA; Clerici L
Cancer; 1984 Aug; 54(3):489-99. PubMed ID: 6428736
[TBL] [Abstract][Full Text] [Related]
3. Lactate dehydrogenase levels in cellular extracts of human malignant lymphomas.
Vezzoni MA; Lucchini R; Giardini R; Raineri M; Murone M; Vezzoni P
Tumori; 1983 Aug; 69(4):279-82. PubMed ID: 6623651
[TBL] [Abstract][Full Text] [Related]
4. Adenosine deaminase and terminal deoxynucleotidyl transferase in human lymphomas: an aid to the diagnosis and subclassification of lymphoblastic lymphomas.
Vezzoni P; Giardini R; Lucchini R; Lombardi L; Vezzoni MA; Besana C; Clerici L
Am J Hematol; 1985 Jul; 19(3):219-27. PubMed ID: 4014222
[TBL] [Abstract][Full Text] [Related]
5. Histologic subtypes and survival of Chinese patients with non-Hodgkin's lymphomas.
Liang R; Loke SL; Ho FC; Chiu E; Chan TK; Todd D
Cancer; 1990 Oct; 66(8):1850-5. PubMed ID: 2208041
[TBL] [Abstract][Full Text] [Related]
6. Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas results of a prospective multicenter study by the Kiel Lymphoma Study Group.
Brittinger G; Bartels H; Common H; Dühmke E; Fülle HH; Gunzer U; Gyenes T; Heinz R; König E; Meusers P
Hematol Oncol; 1984; 2(3):269-306. PubMed ID: 6384008
[TBL] [Abstract][Full Text] [Related]
7. [Classification of non-Hodgkin's lymphomas on the basis of Morphological and immunological features shared by normal and neoplastic lymphatic cells (author's transl)].
Stein H
Immun Infekt; 1976 Apr; 4(2):52-69. PubMed ID: 1085745
[TBL] [Abstract][Full Text] [Related]
8. Combined assay of adenosine deaminase, purine nucleoside phosphorylase, and lactate dehydrogenase in the early clinical evaluation of B-chronic lymphocytic leukemia.
Vives Corrons JL; Rozman C; Pujades MA; Colomer D; Perez Vila E; Anegon I; Gallart T; Vives Puiggrós J; Viñolas N; Montserrat E
Am J Hematol; 1988 Mar; 27(3):157-62. PubMed ID: 3126650
[TBL] [Abstract][Full Text] [Related]
9. A new working formulation of non-Hodgkin's lymphomas. A retrospective study of the new NCI classification proposal in comparison to the Rappaport and Kiel classifications.
Krueger GR; Medina JR; Klein HO; Konrads A; Zach J; Rister M; Janik G; Evers KG; Hirano T; Kitamura H; Bedoya VA
Cancer; 1983 Sep; 52(5):833-40. PubMed ID: 6871825
[TBL] [Abstract][Full Text] [Related]
10. [Non-Hodgkin's lymphomas of low-grade malignancy with particular reference to the lymphocytic lymphomas of B-cell origin (author's transl)].
Wessel H
Arch Geschwulstforsch; 1979; 49(8):635-47. PubMed ID: 317425
[TBL] [Abstract][Full Text] [Related]
11. A clinicopathologic study in advanced non-Hodgkin's lymphomas treated with sequential non-cross-resistant regimens: comparison of the working formulation with the Rappaport and Kiel classifications.
Monfardini S; Rilke F; Valagussa P; Bajetta E; Canetta R; Buzzoni R; Giardini R; Viviani S
Eur J Cancer Clin Oncol; 1984 May; 20(5):609-17. PubMed ID: 6203753
[TBL] [Abstract][Full Text] [Related]
12. [Histological classification of malignant non-Hodgkin's lymphomas and patient survival: the Kiel classification versus the working formulation].
Nizze H; Bühring U
Verh Dtsch Ges Pathol; 1992; 76():110-6. PubMed ID: 1283239
[TBL] [Abstract][Full Text] [Related]
13. Proliferating cell nuclear antigen (PCNA) in non-Hodgkin's lymphomas: correlation with working formulation and Kiel classification in formalin-fixed paraffin-embedded material.
Rabenhorst SH; Burini RC; Schmitt FC
Pathology; 1996 Jan; 28(1):12-6. PubMed ID: 8714262
[TBL] [Abstract][Full Text] [Related]
14. [Retrospective analysis of the clinical relevance of the Kiel classification of malignant non-Hodgkin's lymphomas (author's transl)].
Brittinger G; Bartels H; Bremer K; Burger A; Dühmke E; Gunzer U; König E; Stacher A; Stein H; Theml H; Waldner R
Strahlentherapie; 1977 Apr; 153(4):222-8. PubMed ID: 324031
[TBL] [Abstract][Full Text] [Related]
15. Clinico-pathological features of malignant lymphomas in 294 Hong Kong Chinese patients, retrospective study covering an eight-year period.
Ho FC; Todd D; Loke SL; Ng RP; Khoo RK
Int J Cancer; 1984 Aug; 34(2):143-8. PubMed ID: 6381328
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the working formulation of non-Hodgkin's lymphoma with the Rappaport, Kiel, and Lukes & Collins classifications. Translational value and prognostic significance based on review of 658 patients treated at a single institution.
Ersbøll J; Schultz HB; Hougaard P; Nissen NI; Hou-Jensen K
Cancer; 1985 May; 55(10):2442-58. PubMed ID: 3986740
[TBL] [Abstract][Full Text] [Related]
17. Cell proliferation and DNA content in non-Hodgkin's lymphoma. Flow cytometry in relation to lymphoma classification.
Christensson B; Tribukait B; Linder IL; Ullman B; Biberfeld P
Cancer; 1986 Sep; 58(6):1295-304. PubMed ID: 3742454
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of the Kiel classification of malignant non-Hodgkin's lymphomas.
Bettini R; Chelazzi G
Tumori; 1979 Apr; 65(2):207-13. PubMed ID: 462572
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometry in the diagnosis and classification of malignant lymphoma and leukemia.
Diamond LW; Nathwani BN; Rappaport H
Cancer; 1982 Sep; 50(6):1122-35. PubMed ID: 7104953
[TBL] [Abstract][Full Text] [Related]
20. [Malignant and benign lymphomas: histologic classification and immunomorphologic studies. Results of 838 cases].
Radaszkiewicz T
Wien Klin Wochenschr; 1980 Dec; 92(23):819-33. PubMed ID: 6985528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
